1. Neutrophil-to-lymphocyte ratio predicts cardiovascular events in patients with type 2 diabetes: post hoc analysis of SUSTAIN 6 and PIONEER 6. (14th October 2021) Authors: Verma, S; Husain, M; Madsen, C; Leiter, L A; Rajan, S; Vilsboll, T; Rasmussen, S; Libby, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P2857Increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial. (28th August 2018) Authors: Seufert, J; Nauck, M; Rosenstock, J; Hansen, T; Vrazic, H; Vilsboll, T Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗